Iindaba
Imingeni ekunyangeni ukwahlukana kweSifo seFungal esihlaselayo kwiZigulana zeHematologic Malignancy: Iingcinga ezivela kwi-ASH 2024
KwiNtlanganiso yoNyaka ye-ASH ka-2024, uNjingalwazi uSun Yuqian wabelane ngophando lwakhe oluphambili malunga nesifo sefungus esihlaselayo (bIFD) kwizigulane ezine-hematologic malignancies, egxininisa imingeni yokuxilonga kunye neyonyango, kunye neembono ezisebenzayo ezisekelwe kwizifundo zakutshanje.
Ukuqhubela phambili kwi-T-ALL Risk Stratification: Udidi oluSekelwe kwi-NGS luchonga amaqela amancinci anomngcipheko ophezulu
Uphononongo olutsha olupapashwe kwi Igazi iphucula ulwahlulo lomngcipheko we-T-cell acute lymphoblastic leukemia (T-ALL) isebenzisa ulandelelwano lwesizukulwana esilandelayo (NGS), iphucula uqikelelo lwesifo kunye nokuchonga amaqela amancinci anomngcipheko ophezulu anokungenelwa kunyango olujoliswe kulo.
Ukulawula Iingxaki Zexesha Elide Zonyango lweCAR-T: Ingcaciso Evela Kumhlaza Wendalo
Uphononongo lwakutshanje olupapashwe kwi Umhlaza wendalo igxininisa iingxaki zexesha elide zonyango lweeseli zeCAR-T, igxile kwimingcipheko yosulelo kunye nezifo zesibini zomhlaza, kwaye inika amaqhinga okuphucula iziphumo zesigulana.
Impumelelo Kwezemfundo | Iqela Lezonyango laseLu Daopei Lipapasha Uphando Lweklinikhi Olumangalisayo kwiBritish Journal of Haematology
Iqela lezonyango laseLu Daopei, elikhokelwa nguGqr. Cao Xingyu kunye noNjingalwazi uLu Peihua, lipapashe iphepha lophando lwezonyango elibalulekileyo kwi Ijenali yaseBritane yeHaematology (Impact Factor 5.1). Olu phononongo luphanda ukhuseleko kunye nokusebenza kakuhle kokufakelwa kweeseli ze-hematopoietic stem cell (allo-HSCT) emva konyango lwe-autologous CD7 CAR-T kwi-T-cell engasebenziyo kunye ne-relaxated T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (R/R T-ALL/T-LBL).
Ibali lesigulana | I-Acute Myeloid Leukemia (AML-M2) Survivor: Iminyaka eli-9 emva kokufakelwa, ukwamkela amandla ethemba kunye nokuzalwa ngokutsha
Ibali lesigulana esichukumisayo esivela kwiSibhedlele iLu Daopei, ligxininisa uhambo lomntu oneminyaka engama-32 ubudala osindileyo kwi-AML-M2, emva kokufakelwa i-haploidentical stem cell, ubhiyozela iminyaka eli-9 yokuxolelwa, ephila ubomi obupheleleyo nobuphilayo, ekhuthazwa luthando, ithemba, kunye nokuqina.
Amanqanaba okusinda aphuculweyo nge-Bu/Cy+Melphalan kunye ne-Bu/Cy+Thiotepa Regimens kwi-Haploidentical Stem Cell Transplantation ye-Non-Down Syndrome Acute Megakaryoblastic Leukemia (AMKL)
Uphononongo oluvezwe kwi-ASH 2024 nguGqr. Zhi-Jie Wei kunye neqela lakhe kwiSibhedlele iLu Daopei lubonisa ukusebenza kakuhle kweendlela eziguqulweyo zeBu/Cy kwi-haploidentical hematopoietic stem cell transplantation ye-Non-Down Syndrome Acute Megakaryoblastic Leukemia (AMKL), lubonisa iziphumo ezithembisayo zokusinda kwizigulane ezipheleleyo (CR).
Iziphumo Ezithembisayo Zonyango lwe-CD7 CAR-T Ekunyangeni i-Relapsed/Refractory Peripheral T-Cell Lymphoma kwi-ASH 2024
KwiNtlanganiso yoNyaka ye-ASH ka-2024, uNjingalwazi uLu Peihua waseLu Daopei Hospital uveze iziphumo ezimangalisayo ezivela kuvavanyo lweSigaba soku-1 lwe-CD7 CAR-T cell therapy ye-relapse/refractory peripheral T-cell lymphoma (R/R PTCL), ebonisa ukusebenza okuthembisayo kunye nokhuseleko olulawulekayo.
Ukoyisa Imingeni kwi-CAR-T Therapy ye-T-Cell Blood Cancers
Nangona unyango lwe-CAR-T lutshintshe unyango lomhlaza weeseli ze-B, imingeni ebalulekileyo isekhona ekunyangeni umhlaza weeseli ze-T. Uphononongo lwakutshanje luhlola ubunzima bonyango lwe-CAR-T kumhlaza wegazi weeseli ze-T kunye nezisombululo ezinokubakho zokoyisa le miqobo.
Ukuqhubela phambili kuNyango lokuQala kwi-B-ALL yabantu abadala: Uphononongo olupheleleyo oluvela kwi-Lancet Haematology
Uphononongo lwakutshanje kwi I-Lancet Haematology igxininisa inkqubela phambili ebalulekileyo kunyango lokuqala lwe-B-cell Acute Lymphoblastic Leukemia (B-ALL) yabantu abadala abasandula ukuxilongwa, igxile kwiindlela zonyango ezenzelwe wena, unyango olutsha lwe-immunotherapy, kunye neziphumo eziphuculweyo zesigulana.
Ulutsha Lufumana Ithemba Emva Kokuxilongwa Nge-AML M4a Uhambo Lokuqina Nokuchacha
Emva kokulwa ne-acute myeloid leukemia (AML-M4a) kunye nokufakelwa i-stem cell esindisa ubomi, isigulane esiselula sifumana ithemba, impilo, kunye nesiqalo esitsha, ngenxa yokhathalelo olukhethekileyo lweSibhedlele saseLu Daopei.
Inkqubela Entsha kwiNyango kunye noQwalaselo lweNkqubo yeNervous ePhambili yeLymphoma (PCNSL)
Inkqubela phambili yakutshanje ekuxilongweni nasekunyangweni kwePrimary Central Nervous System Lymphoma (PCNSL) inike ithemba elitsha kwizigulane. Uphononongo lwakutshanje oluvela kwiYunivesithi yaseStanford lubonisa ukubaluleka kokuxilongwa kwangethuba kunye neendlela zonyango zamva nje, kubandakanya i-chemotherapy kunye nonyango olujoliswe kulo.
Ibali lesigulana: Ukoyisa i-Acute Myeloid Leukemia kunye nokuzalwa kwakhona emva kokufakelwa kweStem Cell
Isigulana esiyindoda esineminyaka engama-34 ubudala sibelana ngohambo lwaso olukhuthazayo lokulwa ne-acute myeloid leukemia (AML), sifumana i-chemotherapy kunye nokufakelwa i-stem cell, kwaye sibhiyozela iminyaka emithathu yokuchacha kunye nethemba elitsha.